comparemela.com

Latest Breaking News On - Department of hematology - Page 3 : comparemela.com

Orca-T Offers Favorable Post-Transplant Outcomes in Advanced Hematologic Malignancies

Orca-T Offers Favorable Post-Transplant Outcomes in Advanced Hematologic Malignancies
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Dana farber cancer instituteUnited statesUnited kingdomGlasgow cityJohns hopkinsLeslies keanAmandeep salhotraMeeting of the european society for bloodInternational bloodDivision of leukemiaMarrow transplant clinical trials networkDepartment of hematologyMarrow transplant researchAnnual meetingEuropean societyMarrow transplantationrevealed

Project Optimus: helping or hindering cancer drug development?

Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.

Jay hartenbachFouad namouniR donald harveyDrug administrationResearch development at blueprint medicinesOncology centerDepartment of hematologyDepartment of pharmacologyProject optimusMedical oncologyChemical biologyEmory university schoolClinical trials arenaDrug developmentDonald harveyProject optimus

Dr Jain on the VERONA Study in Higher-Risk MDS

Akriti Jain, MD, discusses the phase 1b VERONA study of venetoclax plus azacitidine in higher-risk myelodysplastic syndromes.

Aakriti jainDepartment of hematologyMedical oncologyCleveland clinic

Dr Aldoss on the Mechanism of Action of Ponatinib in Ph+ ALL

Ibrahim Aldoss, MD, discusses the use of ponatinib as evaluated in the PhALLCON trial for patients with Ph+ ALL.

United statesIbrahim aldossHematology tissue bankDivision of leukemiaLeukemia researchDepartment of hematologyGehr family centerHematopoietic cell transplantationLeukemia registryHematologic oncologyOnclive tvCity of hope

Dr Jain on Unmet Needs in the Treatment of Low- and High-Risk MDS

Akriti Jain, MD, discusses unmet needs in patients with low- and high-risk myelodysplastic syndromes.

Aakriti jainDepartment of hematologyMedical oncologyCleveland clinicMyeloproliferative neoplasmsOnclive tv

vimarsana © 2020. All Rights Reserved.